✦ LIBER ✦

Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations

✍ Scribed by Wu, Jenn-Yu; Wu, Shang-Gin; Yang, Chih-Hsin; Chang, Yih-Leong; Chang, Yeun-Chung; Hsu, Ya-Chieh; Shih, Jin-Yuan; Yang, Pan-Chyr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib effective for patients with NS

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

9167 Outcomes with erlotinib in advanced

✍ Soulières, D.; Ciuleanu, T.; Stelmakh, L.; Whittom, R.; Delmar, P.; Rohr, K.; Br 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Gefitinib, vinorelbine and EGFR mutation

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Coexistence of EGFR mutation and ALK tra

✍ Santelmo, C.; Ravaioli, A.; Barzotti, E.; Papi, M.; Poggi, B.; Drudi, F.; Mangia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 370 KB

EGFR and EML4-ALK gene mutations in NSCL

✍ Tiseo, M.; Gelsomino, F.; Boggiani, D.; Bortesi, B.; Bartolotti, M.; Bozzetti, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 950 KB

Progressive brain metastases in an EGFR

✍ Leitner, C.; von Moos, R.; Mark, M.; Früh, M.; Cathomas, R. 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 812 KB